Lymphoedema is a life-changing condition that affects thousands of Australians living with or recovering from cancer. While cancer treatment saves lives, it can also leave lasting challenges – one of the most common being cancer-related lymphoedema, a chronic condition that causes swelling due to fluid buildup when the lymphatic system is compromised.
“Lymphoedema isn’t just a little bit of swelling – it’s a condition that can have a profound impact on the mind and body,” says Kate Perkins, co-founder of OncoLaser™ and a global leader in lymphoedema care. “From pain and limited mobility to the psychological toll of living with a chronic condition, it affects every aspect of a person’s life. That’s why early detection and the right treatment are so crucial.“
Despite its prevalence, lymphoedema remains underdiagnosed and undertreated, often because symptoms develop gradually. That’s why early intervention is critical. This Lymphoedema Awareness Month, OncoLaser™ is driving change by improving access to non-invasive, cutting-edge treatment that’s transforming patient outcomes.
The Urgent Need for Early Intervention
Lymphoedema can develop after surgery, radiation, or other cancer treatments, particularly in patients recovering from:
✔ Head and Neck Cancer (HNC) – Research shows that over 50% of HNC patients will experience some level of lymphoedema, affecting their ability to swallow, speak, and breathe.
✔ Breast Cancer – Approximately 1 in 5 breast cancer patients will develop Breast Cancer-Related Lymphoedema (BCRL), leading to arm and chest swelling, discomfort, and reduced mobility.
Because it can become worse over time, the earlier it is detected, the better the long-term outcomes. Yet too many patients only seek treatment once symptoms have progressed.
“Lymphoedema can be debilitating, but early detection and targeted treatment can make an enormous difference,” says Kate Perkins. “The sooner we intervene, the better the outcomes. That’s why education and access to effective lymphoedema therapies are so important.”
What is OncoLaser™ and How Does It Work?
OncoLaser™ is a game-changing approach to lymphoedema treatment that uses Photobiomodulation Therapy (PBMT) with MLS® Laser Therapy, a pain-free, non-invasive treatment that:
✅ Reduces swelling
✅ Improves circulation
✅ Supports long-term lymphatic health
Co-founded by Kate Perkins and Dr Catherine Norton, CEO of Heal With Laser, OncoLaser™ is the only certified system of its kind, designed to actively improve patient outcomes rather than just manage symptoms.
“OncoLaser™ is changing the way we approach lymphoedema care,” says Perkins. “It’s not just about reducing discomfort – it’s about helping people regain their quality of life.”
For Patients: A Faster Path to Recovery
Many treatments require ongoing, frequent visits, which can be challenging – especially for those living in regional areas. OncoLaser™ provides an intensive treatment option for patients looking to:
🔹 Achieve significant results quickly
🔹 Reduce the need for frequent, long-term treatments
🔹 Access specialist care without regular travel
With targeted laser therapy, patients can reach maintenance levels sooner, meaning fewer disruptions to daily life.
For Practitioners: A Revolutionary Treatment Option
Healthcare providers looking to expand their lymphoedema services can now integrate OncoLaser™ into their practice. The system comes with:
✔ Comprehensive training to ensure optimal patient outcomes
✔ Cutting-edge technology backed by clinical research
✔ Ongoing support to maximise effectiveness
OncoLaser™ is already available at Coastal Rehab Hub, Belrose-Frenchs Forest Podiatry Centre, Onccare, and Hunter Rehab Hub, with more locations coming soon. This expansion means more patients can access life-changing care, and more practitioners can offer leading-edge treatment.
Join the Movement This Lymphoedema Awareness Month
Lymphoedema Awareness Month is a time to advocate for education, early detection, and better treatment options. World Lymphoedema Day, on 6th March, is a key moment to take action.
Here’s how you can help:
- Spread the word – Share information on social media or within your community.
- Encourage early screening – Healthcare professionals can play a crucial role in detecting lymphoedema before symptoms worsen.
- Expand access to care – More clinics offering OncoLaser™ means more patients receive effective treatment, sooner.
By raising awareness and improving access to advanced therapies like OncoLaser™, we can ensure faster, better outcomes for lymphoedema patients across Australia.
To learn more about OncoLaser™ and how it’s transforming lymphoedema care, contact Kate Perkins on (02) 8006 6665.